NCT06977672 Effects of Down Dog Yoga on Pre-writing Skills in Children With Down Syndrome
| NCT ID | NCT06977672 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2025-04-15 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Down syndrome is a genetic condition caused by an extra chromosome 21, affecting physical and cognitive development. This study will evaluate the effects of down dog yoga on prewriting skills in children with Down syndrome aged 4-8 years. A randomized controlled trial with 32 participants will be conducted at Bahawal Victoria Hospital over 10 months. Assessments will include JTHFT, BBT, and the Prewriting Skills Scale.
Eligibility Criteria
Inclusion Criteria: * Children with age group 4-8years * Both Genders (male female) * Children who can do Independent standing and walking Exclusion Criteria: * Any deformity * Pain and/or symptomatic neurologic/orthopedic dysfunction of upper or lower extremities * Cervical injury and chest wall disorders * Injury * Fractures * History of previous surgery * Children with impaired Fun
Contact & Investigator
Yusra Uzlifat, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06977672 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 8 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06977672 currently recruiting?
Yes, NCT06977672 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06977672 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06977672 clinical trial?
NCT06977672 is sponsored by Riphah International University. The principal investigator is Yusra Uzlifat, MS-PPT at Riphah International University. The trial plans to enroll 34 participants.